Skip to main content
Terug
Watch Compare

Beauty Health Co

Datakwaliteit: 100%
SKIN
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 0,92
▼ € 0,01 (-0,74%)
Marktkapitalisatie: 118,18 M
Prijs
€ 0,92
Marktkapitalisatie
118,18 M
Dagbereik
€ 0,90 — € 0,94
52-Weeksbereik
€ 0,76 — € 2,69
Volume
164.036
Openen € 0,90
50D / 200D Gem.
€ 1,13
18,41% below
50D / 200D Gem.
€ 1,57
41,21% below

Quick Summary

Belangrijkste Punten

Revenue grew 3,70% annually over 5 years — modest growth
Debt/Equity of 5,53 — high leverage
Generating 37,18 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 13,72%
Capital efficient — spends only 0,10% of revenue on capex

Groei

Revenue Growth (5Y)
3,70%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)-10,02%
Earnings (1Y)N/A
FCF Growth (3Y)44,02%

Kwaliteit

Return on Equity
-13,63%
Boven sectorgemiddelde (-53,41%)
ROIC-3,69%
Net Margin-3,16%
Op. Margin-6,92%

Veiligheid

Debt / Equity
5,53
Boven sectorgemiddelde (0,31)
Current Ratio4,98
Interest Coverage-1,08

Waardering

PE (TTM)
-12,41
Onder sectorgemiddelde (-1,48)
P/B Ratio1,80
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -12,4 -1,5
P/B 1,8 1,6
ROE % -13,6 -53,4
Net Margin % -3,2 -41,5
Rev Growth 5Y % 3,7 1,8
D/E 5,5 0,3

ETFs Holding This Stock

GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,02% weight
IWV logo IWV iShares Russell 3000 ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -10,02% Revenue Growth (3Y) -13,06%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 3,70% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 300,79 M Net Income (TTM) -9,52 M
ROE -13,63% ROA -1,88%
Gross Margin 65,28% Operating Margin -6,92%
Net Margin -3,16% Free Cash Flow (TTM) 37,18 M
ROIC -3,69% FCF Growth (3Y) 44,02%
Safety
Debt / Equity 5,53 Current Ratio 4,98
Interest Coverage -1,08 Asset Turnover 0,59
Working Capital 246,46 M Tangible Book Value -98,82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -12,41 Forward P/E N/A
P/B Ratio 1,80 P/S Ratio 0,39
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 31,46%
Market Cap 118,18 M Enterprise Value 481,57 M
Per Share
EPS (Diluted TTM) -0,16 Revenue / Share 2,35
FCF / Share 0,29 OCF / Share 0,29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,10% FCF Conversion -390,61%
SBC-Adj. FCF 18,23 M Growth Momentum -13,72

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue 300,79 M 334,29 M 397,99 M 365,88 M —
Net Income -9,52 M -29,10 M -100,12 M 44,38 M -1,11 M
EPS (Diluted) -0,16 -0,36 -0,76 -0,23 —
Gross Profit 196,36 M 182,30 M 155,11 M 250,34 M —
Operating Income -20,80 M -67,77 M -130,92 M -24,28 M -1,21 M
EBITDA — — — — —
R&D Expenses 5,63 M 6,30 M 10,10 M 8,44 M —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 19,33 M 10,41 M 13,65 M — —
Income Tax 3,58 M -452.000,0 -1,77 M 648.000,0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 499,80 M 685,68 M 929,11 M 1,01 B 464,00 M
Total Liabilities 438,75 M 633,88 M 869,72 M 837,43 M 16,87 M
Shareholders' Equity 61,06 M 51,80 M 59,39 M 171,48 M 5,00 M
Total Debt — — — — —
Cash & Equivalents — — 523,03 M 568,20 M 3,27 M
Current Assets 309,52 M 477,12 M 698,25 M 789,10 M 3,90 M
Current Liabilities 186,28 M 68,15 M 115,01 M 73,12 M 765.497,0